Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management

• Published in: The Journal of urology Vol. 206; no. 4; pp. 806 - 817
• Main Authors: Lerner, Lori B., McVary, Kevin T., Barry, Michael J., Bixler, Brooke R., Dahm, Philipp, Das, Anurag Kumar, Gandhi, Manhar C., Kaplan, Steven A., Kohler, Tobias S., Martin, Leslie, Parsons, J. Kellogg, Roehrborn, Claus G., Stoffel, John T., Welliver, Charles, Wilt, Timothy J.
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA Wolters Kluwer 01.10.2021
• Subjects: PDE5; IPSS; 5ARI; prostate; LUTS; BPH; beta 3 agonist; anticholinergic; alpha blocker

Purpose:Benign prostatic hyperplasia (BPH) is a histologic diagnosis describing proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and severity of lower urinary tract symptoms (LUTS) in aging men are progressive and impact the health and welfare...